Fidelity Investments’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,072,735
| Closed | -$357M | – | 5225 |
|
|
2021
Q3 | $357M | Sell |
2,072,735
-731,204
| -26% | -$95.6M | 0.03% | 555 |
|
|
2021
Q2 | $352M | Sell |
2,803,939
-922,733
| -25% | -$116M | 0.03% | 584 |
|
|
2021
Q1 | $505M | Sell |
3,726,672
-951,743
| -20% | -$123M | 0.04% | 431 |
|
|
2020
Q4 | $599M | Sell |
4,678,415
-1,162,445
| -20% | -$136M | 0.05% | 350 |
|
|
2020
Q3 | $657M | Sell |
5,840,860
-1,835,297
| -24% | -$183M | 0.07% | 265 |
|
|
2020
Q2 | $731M | Sell |
7,676,157
-323,915
| -4% | -$31.2M | 0.08% | 221 |
|
|
2020
Q1 | $719M | Buy |
8,000,072
+37,837
| +0.5% | +$2.94M | 0.1% | 189 |
|
|
2019
Q4 | $422M | Buy |
7,962,235
+2,014,679
| +34% | +$91.9M | 0.05% | 376 |
|
|
2019
Q3 | $235M | Sell |
5,947,556
-498,290
| -8% | -$21.6M | 0.03% | 575 |
|
|
2019
Q2 | $265M | Sell |
6,445,846
-918,107
| -12% | -$38M | 0.03% | 553 |
|
|
2019
Q1 | $343M | Buy |
7,363,953
+435,414
| +6% | +$19.1M | 0.04% | 432 |
|
|
2018
Q4 | $302M | Buy |
6,928,539
+28,170
| +0.4% | +$1.41M | 0.04% | 434 |
|
|
2018
Q3 | $395M | Buy |
6,900,369
+2,494,546
| +57% | +$123M | 0.04% | 405 |
|
|
2018
Q2 | $214M | Sell |
4,405,823
-761,567
| -15% | -$27.7M | 0.02% | 633 |
|
|
2018
Q1 | $202M | Buy |
5,167,390
+61,003
| +1% | +$2.59M | 0.02% | 678 |
|
|
2017
Q4 | $217M | Buy |
5,106,387
+1,379,713
| +37% | +$51.7M | 0.03% | 655 |
|
|
2017
Q3 | $139M | Sell |
3,726,674
-1,004,329
| -21% | -$34.9M | 0.02% | 825 |
|
|
2017
Q2 | $144M | Sell |
4,731,003
-107,084
| -2% | -$3.1M | 0.02% | 813 |
|
|
2017
Q1 | $128M | Sell |
4,838,087
-402,066
| -8% | -$10.6M | 0.02% | 885 |
|
|
2016
Q4 | $134M | Sell |
5,240,153
-395,032
| -7% | -$12.5M | 0.02% | 842 |
|
|
2016
Q3 | $204M | Buy |
5,635,185
+68,000
| +1% | +$2.25M | 0.03% | 660 |
|
|
2016
Q2 | $189M | Buy |
5,567,185
+7,024
| +0.1% | +$228K | 0.03% | 688 |
|
|
2016
Q1 | $147M | Buy |
5,560,161
+572,176
| +11% | +$16.6M | 0.02% | 805 |
|
|
2015
Q4 | $243M | Buy |
4,987,985
+29,124
| +0.6% | +$1.05M | 0.03% | 578 |
|
|
2015
Q3 | $123M | Buy |
4,958,861
+37,066
| +0.8% | +$1.11M | 0.02% | 871 |
|
|
2015
Q2 | $156M | Buy |
4,921,795
+25,147
| +0.5% | +$812K | 0.02% | 822 |
|
|
2015
Q1 | $186M | Buy |
4,896,648
+58,670
| +1% | +$2.33M | 0.02% | 726 |
|
|
2014
Q4 | $188M | Buy |
4,837,978
+68,416
| +1% | +$2.38M | 0.02% | 707 |
|
|
2014
Q3 | $144M | Buy |
4,769,562
+51,198
| +1% | +$1.44M | 0.02% | 800 |
|
|
2014
Q2 | $160M | Buy |
4,718,364
+2,115,587
| +81% | +$70.7M | 0.02% | 762 |
|
|
2014
Q1 | $89.8M | Buy |
2,602,777
+799,377
| +44% | +$36.1M | 0.01% | 1040 |
|
|
2013
Q4 | $71.4M | Buy |
+1,803,400
| New | +$43.5M | 0.01% | 1140 |
|